FDA Approved: ZAVESCA — Supplemental Application (Actelion Pharmaceuticals US, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for ZAVESCA (miglustat) from Actelion Pharmaceuticals US, updating the labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Niemann-pick Disease Type

Drugs mentioned

• Zavesca (Miglustat)

Snippet

SUPPL AP for ZAVESCA (MIGLUSTAT)